<DOC>
	<DOCNO>NCT01290744</DOCNO>
	<brief_summary>This study double-blind , randomize control trial examine effect ENL reaction give additional year clofazimine completion MDT leprosy .</brief_summary>
	<brief_title>Effect Additional Clofazimine Erythema Nodosum Leprosum ( ENL ) Reactions Leprosy</brief_title>
	<detailed_description>Clofazimine anti-bacterial agent use treat leprosy ; normal component WHO-recommended multi-drug therapy ( MDT ) . It also know beneficial effect one common immunological reaction occur leprosy , know erythema nodosum leprosum , ENL . When MDT reduce length 24 12 month , evidence suggest ENL become bad . This study double-blind , randomize control trial examine effect give additional year clofazimine completion MDT . The endpoint incidence severity ENL period 3 year 2 group .</detailed_description>
	<mesh_term>Leprosy</mesh_term>
	<mesh_term>Leprosy , Lepromatous</mesh_term>
	<mesh_term>Leprosy , Multibacillary</mesh_term>
	<mesh_term>Leprosy , Borderline</mesh_term>
	<mesh_term>Clofazimine</mesh_term>
	<criteria>15 70 year age MB leprosy Pretreatment BI 4 site Consent Presence another serious illness Refusal inform consent</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>leprosy</keyword>
	<keyword>ENL</keyword>
	<keyword>clofazimine</keyword>
</DOC>